Celgene Welcomes Jounce to its Immuno-Oncology Collaborators List with US$2.56 B Deal
By Jawala Prasad & Heather Cartwright
Pharma Deals Review: Vol 2016 Issue 8 (Table of Contents)
Published: 2 Aug-2016
DOI: 10.3833/pdr.v2016.i8.2179 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In the latest in a stream of immuno-oncology alliances, Celgene has partnered with start-up Jounce Therapeutics in a deal potentially worth up to US$2...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS